Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Antibe Therapeutics Inc | ATE | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.295 | 0.295 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.15 - 1.23 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.295 | CAD |
Antibe Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.26M | 52.62M | - | 6.99M | -19.48M | -0.37 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Antibe Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATE Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.45 | 0.465 | 0.15 | 0.228571 | 235,481 | -0.155 | -34.44% |
6 Months | 0.71 | 1.14 | 0.15 | 0.5338808 | 120,005 | -0.415 | -58.45% |
1 Year | 0.50 | 1.23 | 0.15 | 0.6001458 | 76,039 | -0.205 | -41.00% |
3 Years | 4.00 | 4.10 | 0.15 | 1.02 | 83,264 | -3.71 | -92.63% |
5 Years | 0.415 | 7.52 | 0.15 | 1.86 | 108,272 | -0.12 | -28.92% |
Antibe Therapeutics Description
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. |